Real world effectiveness of sotrovimab in preventing COVID-19–related hospitalisation or death in patients infected with Omicron BA.2
Background: Laboratory-based evidence indicates that neutralization of the BA.2 (Omicron) variant by sotrovimab is reduced versus previous SARS-CoV-2 variants. Since there is a lack of real-world data, we investigated whether sotrovimab has reduced clinical efficacy against the BA.2 variant. Methods...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2024-02-01
|
| Colección: | Journal of Infection and Public Health |
| Materias: | |
| Acceso en línea: | http://www.sciencedirect.com/science/article/pii/S1876034123004355 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|